Skip to main content
    O

    Omega Healthcare Investors Inc (OHI)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE

    $47.08
    +0.03 (+0.06%)

    Market Cap: $14.97B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Omega Healthcare Investors Inc (OHI) Financials: Revenue, Profit and Cash Flow

    Updated Jul 29, 2026. Financial statements from company filings, amounts in US dollars.

    Omega Healthcare Investors reported revenue of $975.06M for the fiscal year ended Dec 31, 2025, up 15.7% from the year before. That year, net income was $609.47M with a net margin of 62.5%, operating cash flow was $878.55M and free cash flow was $797.68M. The quarter ended Jun 30, 2026 had revenue of $526.65M and net income of $379.67M.

    Revenue and Margins

    The operating margin was 76.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $1.73B, a compound annual decline of 6.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$975.06M+15.7%54.7%76.9%62.5%
    Dec 2024$842.84M+6.2%123.0%78.3%49.6%
    Dec 2023$793.88M-21.0%117.7%61.6%31.3%
    Dec 2022$1.00B+21.4%85.8%39.0%43.7%
    Dec 2021$827.62M+20.3%126.9%68.4%51.8%
    Dec 2020$688.11M-11.3%127.9%65.7%23.8%
    Dec 2019$775.81M+10.0%117.8%71.1%45.4%
    Dec 2018$705.03M-26.8%125.1%70.6%41.7%
    Dec 2017$963.19M-44.3%94.3%32.7%10.9%
    Dec 2016$1.73BN/A52.1%32.4%44.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 45.9% from the year before. In the quarter ended Jun 2026, net income rose 170.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$975.06M$842.84M$793.88M$1.00B$827.62M$688.11M$775.81M$705.03M$963.19M$1.73B
    Cost of revenue$664.93M$14.56M$15.03M$15.50M$12.26M$12.32M$14.93M$29.84M$99.07M$58.73M
    Gross profit$533.17M$1.04B$934.72M$862.74M$1.05B$880.07M$913.90M$881.68M$908.38M$900.83M
    Operating income$749.44M$659.66M$488.97M$392.28M$566.17M$452.25M$551.75M$497.59M$315.17M$559.95M
    Net income$609.47M$417.80M$248.80M$438.84M$428.30M$163.54M$351.95M$293.88M$104.91M$766.73M
    EBITDA$895.60M$732.46M$569.70M$778.61M$821.67M$503.89M$648.37M$575.70M$611.46M$1.21B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$526.65M$276.22M$229.13M$281.75M$252.50M$234.58M$225.96M$221.10M$211.69M$184.09M$258.53M$183.25M
    Gross profitN/A$313.94M$151.95M$308.09M$279.25M$273.47M$275.87M$272.46M$249.00M$239.50M$203.19M$238.14M
    Operating incomeN/A$207.08M$204.31M$206.10M$179.68M$156.45M$175.42M$182.52M$166.78M$134.94M$184.66M$134.32M
    Net income$379.67M$158.58M$171.97M$184.96M$140.48M$112.06M$116.47M$114.91M$117.08M$69.35M$56.52M$93.91M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $4.26B exceeded cash and equivalents by $4.23B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$10.05B$9.90B$9.12B$9.41B$9.64B$9.50B$9.80B$17.18B$8.77B$8.95B
    Current assets$2.06B$2.64B$2.23B$1.77B$1.39B$1.39B$1.23B$1.20B$1.50B$1.64B
    Cash and equivalents$27.02M$518.34M$442.81M$297.10M$20.53M$163.53M$24.12M$20.60M$85.94M$93.69M
    Total liabilities$4.61B$5.17B$5.36B$5.60B$5.53B$5.46B$5.46B$4.67B$4.89B$4.74B
    Short-term debt$242.00M$0$20.40M$19.25M$0$101.16M$125.00M$313.00M$290.00M$190.00M
    Long-term debt$4.01B$4.84B$5.05B$5.27B$5.25B$5.07B$5.01B$4.33B$4.28B$4.18B
    Shareholder equity$5.18B$4.54B$3.57B$3.61B$3.91B$3.84B$4.14B$3.44B$3.56B$3.86B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$10.01B$10.23B$10.05B$10.60B$10.55B$9.71B$9.90B$9.57B$8.85B$9.01B$9.12B$9.43B
    Total liabilities$4.37B$4.78B$4.61B$5.35B$5.36B$4.77B$5.17B$5.17B$4.95B$5.31B$5.36B$5.57B
    Cash and equivalents$39.04M$26.15M$27.02M$737.19M$734.18M$367.96M$518.34M$342.44M$35.19M$361.77M$442.81M$554.71M
    Shareholder equity$5.39B$5.19B$5.18B$5.04B$4.99B$4.74B$4.54B$4.21B$3.71B$3.51B$3.57B$3.67B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 90.8% of operating cash flow. Dividends came to 103.3% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$878.55M$749.43M$617.74M$625.73M$722.14M$708.26M$553.75M$499.37M$577.91M$624.77M
    Capital expenditures$80.87M$37.76M$38.01M$47.22M$44.95M$106.18M$52.89M$169.26M$124.45M$109.45M
    Free cash flow$797.68M$711.67M$579.73M$578.51M$677.19M$602.07M$500.86M$330.11M$453.46M$515.32M
    Dividends paid$824.27M$714.70M$670.26M$653.39M$662.88M$612.31M$585.42M$528.70M$502.60M$453.15M
    Share repurchasesN/AN/AN/A$142.27M$0$0N/AN/AN/AN/A
    Investing cash flow-$539.79M-$671.16M-$770.00K$442.85M-$524.17M-$89.06M-$378.95M-$173.22M-$285.13M-$1.11B
    Financing cash flow-$838.26M$26.32M-$473.31M-$789.45M-$341.12M-$485.55M-$153.96M-$410.70M-$303.81M$576.30M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$217.72M$215.50M$230.62M$226.71M$239.26M$181.95M$228.97M$184.88M$184.10M$151.47M$164.98M$171.02M
    Capital expenditures$13.85M$12.82M$26.69M$21.23M$2.31M$35.25M$15.48M$8.27M$7.44M$21.45M$14.71M$10.11M
    Free cash flow$203.87M$202.68M$203.93M$205.48M$236.95M$146.70M$213.49M$176.62M$176.67M$130.03M$150.27M$160.91M
    Last 12 quarters

    Frequently Asked Questions About OHI

    What is Omega Healthcare Investors' annual revenue?

    Omega Healthcare Investors reported revenue of $975.06M for the fiscal year ended Dec 31, 2025.

    How fast is Omega Healthcare Investors' revenue growing?

    Revenue was up 15.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.0%.

    Is Omega Healthcare Investors profitable?

    Yes. Omega Healthcare Investors reported net income of $609.47M for the fiscal year ended Dec 31, 2025, with a net margin of 62.5%.

    How much free cash flow does OHI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $878.55M minus capital expenditures of $80.87M produced free cash flow of $797.68M.

    How much debt does Omega Healthcare Investors have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $4.01B, short-term debt of $242.00M and cash and equivalents of $27.02M.